Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001432012 | SCV001634776 | likely benign | Noonan syndrome 9 | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002358967 | SCV002621941 | likely benign | Cardiovascular phenotype | 2019-09-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001432012 | SCV002762963 | likely benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003388016 | SCV004099713 | likely benign | not specified | 2023-09-11 | criteria provided, single submitter | clinical testing |